Tuesday, 5 May 2026

Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly's GLP-1 dominance

Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly's GLP-1 dominance submitted by /u/cnbc_official
[link] [comments]


from Health https://ift.tt/nyCe0R1
via IFTTT

No comments:

Post a Comment